Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Marciani P
,
Trotti D
,
Hediger MA
,
Monticelli G
.
???displayArticle.abstract???
Iron(II) exacerbates the effects of oxidative stress via the Fenton reaction. A number of human diseases are associated with iron accumulation including ischemia-reperfusion injury, inflammation and certain neurodegenerative diseases. The functional properties and localization in plasma membrane of cells and endosomes suggest an important role for the divalent metal transporter DMT1 (also known as DCT1 and Nramp2) in iron transport and cellular iron homeostasis. Although iron metabolism is strictly controlled and the activity of DMT1 is central in controlling iron homeostasis, no regulatory mechanisms for DMT1 have been so far identified. Our studies show that the activity of DMT1 is modulated by compounds that affect its redox status. We also show that both iron and zinc are transported by DMT1 when expressed in Xenopus laevis oocytes. Radiotracer uptake and electrophysiological measurements revealed that H(2)O(2) and Hg(2+) treatments result in substantial inhibition of DMT1. These findings may have a profound relevance from a physiological and pathophysiological standpoint.
Aizenman,
Oxygen free radicals regulate NMDA receptor function via a redox modulatory site.
1990, Pubmed
Aizenman,
Oxygen free radicals regulate NMDA receptor function via a redox modulatory site.
1990,
Pubmed
Babior,
Oxygen-dependent microbial killing by phagocytes (first of two parts).
1978,
Pubmed
Bannon,
Effect of DMT1 knockdown on iron, cadmium, and lead uptake in Caco-2 cells.
2003,
Pubmed
Brazzolotto,
Human cytoplasmic aconitase (Iron regulatory protein 1) is converted into its [3Fe-4S] form by hydrogen peroxide in vitro but is not activated for iron-responsive element binding.
1999,
Pubmed
Burdo,
Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat.
2001,
Pubmed
Burdo,
Cellular distribution of iron in the brain of the Belgrade rat.
1999,
Pubmed
Caltagirone,
Modulation of cellular iron metabolism by hydrogen peroxide. Effects of H2O2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts.
2001,
Pubmed
Canonne-Hergaux,
Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron.
1999,
Pubmed
Dexter,
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
1989,
Pubmed
Fantini,
Deferoxamine prevents lipid peroxidation and attenuates reoxygenation injury in postischemic skeletal muscle.
1993,
Pubmed
Finkel,
Oxidants, oxidative stress and the biology of ageing.
2000,
Pubmed
Finkel,
Oxygen radicals and signaling.
1998,
Pubmed
Fleming,
Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport.
1998,
Pubmed
Fleming,
Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1.
1999,
Pubmed
Fridovich,
Superoxide radical and superoxide dismutases.
1995,
Pubmed
Gerlach,
Altered brain metabolism of iron as a cause of neurodegenerative diseases?
1994,
Pubmed
Goswami,
Iron transport: emerging roles in health and disease.
2002,
Pubmed
Gruenheid,
Identification and characterization of a second mouse Nramp gene.
1995,
Pubmed
Gunshin,
Cloning and characterization of a mammalian proton-coupled metal-ion transporter.
1997,
Pubmed
,
Xenbase
He,
Time-course and localization of transferrin receptor expression in the substantia nigra of 6-hydroxydopamine-induced parkinsonian rats.
1999,
Pubmed
Hubert,
Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function.
2002,
Pubmed
Jellinger,
The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.
1999,
Pubmed
Kaltschmidt,
Activation of NF-kappa B by reactive oxygen intermediates in the nervous system.
1999,
Pubmed
Kaur,
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.
2003,
Pubmed
Kim,
Hydrogen peroxide-induced current in Xenopus oocytes: current characteristics similar to those induced by the removal of extracellular calcium.
2002,
Pubmed
,
Xenbase
Knöpfel,
Characterization of an integral protein of the brush border membrane mediating the transport of divalent metal ions.
2000,
Pubmed
Lee,
The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
1998,
Pubmed
McCord,
Oxygen-derived free radicals in postischemic tissue injury.
1985,
Pubmed
McCord,
Oxygen-derived radicals: a link between reperfusion injury and inflammation.
1987,
Pubmed
Omar,
Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation.
1989,
Pubmed
Pantopoulos,
Differences in the regulation of iron regulatory protein-1 (IRP-1) by extra- and intracellular oxidative stress.
1997,
Pubmed
Pantopoulos,
Activation of iron regulatory protein-1 by oxidative stress in vitro.
1998,
Pubmed
Ponka,
Function and regulation of transferrin and ferritin.
1998,
Pubmed
Qian,
Transferrin-bound iron uptake by the cultured cerebellar granule cells.
1998,
Pubmed
Qian,
Cerebellar granule cells acquire transferrin-free iron by a carrier-mediated process.
1999,
Pubmed
Richardson,
The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells.
1997,
Pubmed
Rolfs,
Intestinal expression of genes involved in iron absorption in humans.
2002,
Pubmed
Ruppersberg,
Regulation of fast inactivation of cloned mammalian IK(A) channels by cysteine oxidation.
1991,
Pubmed
,
Xenbase
Sacher,
Properties of the mammalian and yeast metal-ion transporters DCT1 and Smf1p expressed in Xenopus laevis oocytes.
2001,
Pubmed
,
Xenbase
Stadtman,
Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions.
1993,
Pubmed
Thannickal,
Activation of an H2O2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1.
1995,
Pubmed
Trotti,
Differential modulation of the uptake currents by redox interconversion of cysteine residues in the human neuronal glutamate transporter EAAC1.
1997,
Pubmed
,
Xenbase
Trotti,
SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter.
1999,
Pubmed
,
Xenbase
Trotti,
Neuronal and glial glutamate transporters possess an SH-based redox regulatory mechanism.
1997,
Pubmed
Trotti,
Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?
1998,
Pubmed
van der Kraaij,
Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine.
1988,
Pubmed
van Iwaarden,
What we can learn from the effects of thiol reagents on transport proteins.
1992,
Pubmed
